» Articles » PMID: 16829300

Neutrophils in Development of Multiple Organ Failure in Sepsis

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2006 Jul 11
PMID 16829300
Citations 277
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple organ failure is a major threat to the survival of patients with sepsis and systemic inflammation. In the UK and in the USA, mortality rates are currently comparable with and projected to exceed those from myocardial infarction. The immune system combats microbial infections but, in severe sepsis, its untoward activity seems to contribute to organ dysfunction. In this Review we propose that an inappropriate activation and positioning of neutrophils within the microvasculature contributes to the pathological manifestations of multiple organ failure. We further suggest that targeting neutrophils and their interactions with blood vessel walls could be a worthwhile therapeutic strategy for sepsis.

Citing Articles

Leveraging diverse cell-death patterns in diagnosis of sepsis by integrating bioinformatics and machine learning.

Liu M, Gao X, Wang H, Zhang Y, Li X, Zhu R PeerJ. 2025; 13:e19077.

PMID: 40028203 PMC: 11871900. DOI: 10.7717/peerj.19077.


The effects of dexmedetomidine on liver injury in rats with experimental sepsis: A histopathological and immunohistochemical study.

Keles O, Sayhan Kaplan H, Cicek H, Palabiyik O, Yener Z Ulus Travma Acil Cerrahi Derg. 2025; 31(2):112-118.

PMID: 39963913 PMC: 11843427. DOI: 10.14744/tjtes.2025.55338.


Vascular endothelial cell injury: causes, molecular mechanisms, and treatments.

Xia T, Yu J, Du M, Chen X, Wang C, Li R MedComm (2020). 2025; 6(2):e70057.

PMID: 39931738 PMC: 11809559. DOI: 10.1002/mco2.70057.


Comparing the Prognostic Value of Lactate to the Neutrophil to Lymphocyte Ratio Among Sepsis Patients: A Prospective Cohort Study.

Bou Chebl R, Haidar S, Kattouf N, Assaf M, Alwan J, Khamis M Open Access Emerg Med. 2025; 17:3-13.

PMID: 39867261 PMC: 11759577. DOI: 10.2147/OAEM.S486966.


Selective Cytopheretic Device (QUELimmune): A Leukocyte Processing, Immunomodulatory Device.

Pino C, Johnston K, Westover A, Humes H J Am Soc Nephrol. 2024; 36(1):144-146.

PMID: 39500306 PMC: 11706555. DOI: 10.1681/ASN.0000000569.